EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasionFulvia Farabegoli(University of Bologna), Alessio Papi(University of Bologna)Bioscience ReportsMay 3, 201710.1042/bsr20170168Cited by 59SaveCiteExport RISWatch citationsRelated Papers(–)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells|Bioscience Reports|2010|83